Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696). - Wikidata - awgldk - TriplyDB

Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).

Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).

http://www.wikidata.org/entity/Q40841838

about

Cancer vaccines Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma.Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines.Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.Tumor lysate-loaded biodegradable microparticles as cancer vaccines.Recent progress in peptide vaccination in cancer with a focus on non-small-cell lung cancer.Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8(+) effector T cell responses.Immune responses to cancer: are they potential biomarkers of prognosis?Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma.Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients

P2860

Q27024438-F442498A-3D79-4210-A17C-D317FC230046 Q30412300-2FBB408C-F2E4-48BF-B1ED-48014A33E85A Q36983356-5AB8393F-C64E-493A-9D43-D526AB131E2F Q37414561-D2730139-A1E7-466E-9ACF-B88FCD6A6DDB Q37670779-B571F716-672A-426B-BAEC-80F9F82701F8 Q38168904-FF39E45A-B12C-4E45-AAE2-59F38B2860D5 Q38764852-EBB04EA4-13DF-443C-9D48-022BFEFD30CD Q39313889-AE80E3D1-DA07-4EBE-94FD-8AA924062814 Q39546506-B93D2A79-66B7-44B0-836F-D678DB3B5CF7 Q40778413-5F04AD94-3422-4E88-9663-98009F5495CD Q41237376-2D726F09-86E2-4526-B6A8-F79D4627D3D7 Q42129387-047A0555-7099-4F8B-92D6-3EFD8C5A9D8D Q58129598-93B6E126-B26C-4142-AC12-1DDEE5D03F1E

P2860

Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).

http://www.wikidata.org/entity/Q40841838

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Function but not phenotype of ...... ide vaccine trial (ECOG 1696).

@en

type

label

Function but not phenotype of ...... ide vaccine trial (ECOG 1696).

@en

prefLabel

Function but not phenotype of ...... ide vaccine trial (ECOG 1696).

@en

P1433

Q40841838-546C193D-3BDF-471B-93B5-CB60639FE395

P1476

Q40841838-9EBBE7AC-B721-43A2-B505-5E92BA325E99

P2093

Q40841838-4000FC4C-412D-4BF0-B882-281ABD99B03F

Q40841838-6505796C-27D4-4CF3-8C1A-104625D2D21E

Q40841838-83C768FD-7C8A-4C21-AB66-12062B905ED1

Q40841838-F2E53AE1-9E19-49C1-8A14-657D4F0BF5A8

Q40841838-F84B673B-C80B-4580-A8B6-F3422041AFED

Q40841838-FDB2F63D-05FA-4B4D-9B6F-EF4FE02C4149

P2860

Q40841838-052A31E4-38C6-4446-8860-D463EBE7B03D

Q40841838-065E6E4C-557A-43CA-8B43-A6B7F37B92E5

Q40841838-09C6655D-471F-4DD7-9101-2C518904A8F9

Q40841838-11C25B45-51BB-46AF-9968-259C355DD918

Q40841838-15E11AB9-E29A-44D1-A2BF-1412CDF34141

Q40841838-17087C02-F5E7-4B8F-B151-8CE1D1E70C4C

Q40841838-19D9C473-1611-4273-8E78-E2BB5BCF867D

Q40841838-1D956C22-04DE-43AA-9702-357848C0DA91

Q40841838-210CEB9B-17E2-423F-922C-C5A0A991BD76

Q40841838-3A14EB43-D4FB-45A1-940C-8A588D05D498

P304

Q40841838-3F5535BE-E66E-4624-935D-4E97A7465696

P31

Q40841838-A215B5C6-D1C3-4505-B1B2-DE24654D4B29

P356

Q40841838-B3B59C30-0577-411E-B3C4-8C74728E4221

P433

Q40841838-7AFCE2FC-EED9-4ACC-8E38-2DBD5CC737FC

P478

Q40841838-D7863D1C-6287-41A8-B209-E672374FF54A

P50

Q40841838-292C8E1A-8A03-47A5-B263-AF0260CBC1C0

Q40841838-AD58CC55-EB55-454E-A023-4E24CB2F16B0

P577

Q40841838-01AF9CEF-B199-43AF-9945-E23875CDF5E0

P5875

Q40841838-9342D0DE-6565-4730-A349-BC681A7CD70B

P698

Q40841838-027884CB-E5D1-4F76-8B0A-49F4DBF0995C

P932

Q40841838-09FA379F-F7C0-4262-B174-26A3844C20E2

P356

P1433

International Journal of Cancer

P1476

Function but not phenotype of ...... tide vaccine trial (ECOG 1696)

@en

P2093

Carmen Visus

http://www.w3.org/2001/XMLSchema#string

Carsten Schaefer

http://www.w3.org/2001/XMLSchema#string

Grace G Kim

http://www.w3.org/2001/XMLSchema#string

John M Kirkwood

http://www.w3.org/2001/XMLSchema#string

Sandra Lee

http://www.w3.org/2001/XMLSchema#string

Theresa L Whiteside

http://www.w3.org/2001/XMLSchema#string

P2860

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma.

Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.

In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells.

Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine

Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines

Phenotype and function of human T lymphocyte subsets: consensus and issues.

P304

874-884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.26481

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Lisa H. Butterfield

Andreas E. Albers

P577

2012-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51736478

http://www.w3.org/2001/XMLSchema#string

P698

22021080

http://www.w3.org/2001/XMLSchema#string

P932

3658448

http://www.w3.org/2001/XMLSchema#string